7 months ago
TTD
AnalystsJason ButlerJason Butler's Stock Forecasts
AnalystsJason Butler
Analyst Ranking
Top 1%
#45 out of 5150 analysts
Average Return
+46.43%
Win Rate
52%83 out of 161
Risk vs Reward
Poor
Good
Jason Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abivax SaABVX | +1,746.25% | $6.80 | $125.55 | 2025-03-18 - 2025-12-12 | Buy |
Abivax SaABVX | +1,663.27% | $7.12 | $125.55 | 2025-04-30 - 2025-12-12 | Buy |
Abivax SaABVX | +1,147.81% | $8.89 | $110.93 | 2024-12-04 - 2025-12-03 | Buy |
Rezolute IncRZLT | +613.92% | $0.79 | $5.64 | 2023-11-14 - 2024-11-13 | Buy |
Morphosys AgMOR | +316.70% | $4.55 | $18.96 | 2023-11-21 - 2024-08-02 | Buy |
Jason Butler Analyst Color
Get additional color on Jason Butler's coverage of popular stocks
Jason Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | 12 | Buy | $19.00 | +83.40% | Maintains | 12 days ago |
Halozyme Therapeutics IncHALO | 10 | Buy | $92.00 | +47.89% | Maintains | a month ago |
Aquestive Therapeutics IncAQST | 8 | Buy | $12.00 | +93.24% | Maintains | 2 months ago |
Abivax SaABVX | 4 | Buy | $95.00 | -24.33% | Maintains | 5 months ago |
Rapport Therapeutics IncRAPP | 2 | Buy | $28.00 | -7.50% | Reiterates | 5 months ago |
Acadia Pharmaceuticals IncACAD | 13 | Buy | $37.00 | +36.28% | Reiterates | 6 months ago |
Gh Research PLCGHRS | 5 | Buy | $39.00 | +199.19% | Reiterates | 6 months ago |
Precigen IncPGEN | 11 | Buy | $6.00 | +62.60% | Reiterates | 6 months ago |
Trade Desk IncTTD | 1 | Buy | $100.00 | +172.85% | Maintains | 7 months ago |
Viridian Therapeutics IncVRDN | 6 | Buy | $38.00 | +17.61% | Maintains | 7 months ago |
Cytokinetics IncCYTK | 16 | Buy | $78.00 | +23.13% | Reiterates | 8 months ago |
Zevra Therapeutics IncZVRA | 2 | Buy | $18.00 | +116.09% | Maintains | 9 months ago |
Esperion Therapeutics IncESPR | 2 | Buy | $4.00 | +3.90% | Reiterates | 9 months ago |
Argenx SeARGX | 8 | Buy | $701.00 | -20.15% | Maintains | 9 months ago |
Dynavax Technologies CorpDVAX | 1 | Buy | $33.00 | +205.56% | Maintains | 10 months ago |
Rezolute IncRZLT | 8 | Buy | $9.00 | +400.00% | Maintains | 10 months ago |
Vigil Neuroscience IncVIGL | 4 | Buy | $22.00 | N/A | Reiterates | a year ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $4.00 | N/A | Maintains | a year ago |
Hookipa Pharma IncHOOK | 3 | Buy | $23.00 | N/A | Maintains | a year ago |
Athira Pharma IncATHA | 5 | Buy | $190.00 | N/A | Reiterates | a year ago |
Cormedix IncCRMD | 6 | Buy | $19.00 | N/A | Reiterates | 2 years ago |
Morphosys AgMOR | 3 | Buy | $17.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 6 | Buy | $318.00 | N/A | Reiterates | 2 years ago |
Gamida Cell LtdGMDAQ | 9 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Trevena IncTRVN | 2 | Buy | $50.00 | N/A | Reiterates | 3 years ago |
Minerva Neurosciences IncNERV | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Plx Pharma IncPLXPQ | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Applied Molecular Transport IncAMTI | 2 | Buy | $50.00 | N/A | Maintains | 4 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Buy | $22.00 | N/A | Maintains | 4 years ago |
Quince Therapeutics IncQNCX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Enanta Pharmaceuticals IncENTA | 4 | Buy | $116.00 | N/A | Maintains | 4 years ago |
Arbutus Biopharma CorpABUS | 1 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Pfenex IncPFNX | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zogenix IncZGNX | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 8 years ago |
Intra Cellular Therapies IncITCI | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.